What new payment policy is CMS implementing to support the use of domestically sourced Mo-99 in nuclear cardiology imaging?
Starting on January 1, 2026, CMS will introduce a $10 per dose add-on payment for technetium-99m (Tc-99m) radiopharmaceuticals produced from domestically sourced molybdenum-99 (Mo-99). This move directly supports cardiology practices by ensuring the availability of sustainable, domestically produced sources for nuclear imaging. This is particularly critical for the diagnostic imaging needed for heart disease and will help alleviate concerns about supply chain disruptions.
This question was answered in our annual Cardiology Reimbursement & Compliance Update webcast. For more hot topics relating to cardiology services, please visit our store or call us at 1.800.252.1578, ext. 2.
CPT® copyright 2024 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
Copyright © 2025 ICD10monitor. Powered by MedLearn Media.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24